BSR has published an updated life-course guideline for the prescription and monitoring of conventional synthetic disease modifying anti-rheumatic drugs (csDMARDs). Find out more via our blog. Join guideline working group Chair, Louise Mercer, and group members James Galloway, Katie Bechman, Akhila Kavirayani and Alan Davidson, in a roundtable discussion hosted by Prof Ernest Choy, Editor in Chief of Rheumatology to find out what is included in the publication and what has changed since ...
All content for Talking Rheumatology is the property of British Society for Rheumatology and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
BSR has published an updated life-course guideline for the prescription and monitoring of conventional synthetic disease modifying anti-rheumatic drugs (csDMARDs). Find out more via our blog. Join guideline working group Chair, Louise Mercer, and group members James Galloway, Katie Bechman, Akhila Kavirayani and Alan Davidson, in a roundtable discussion hosted by Prof Ernest Choy, Editor in Chief of Rheumatology to find out what is included in the publication and what has changed since ...
Ep 30. GUIDELINES - BSR management recommendations for ANCA-associated vasculitis 2025
Talking Rheumatology
22 minutes
5 months ago
Ep 30. GUIDELINES - BSR management recommendations for ANCA-associated vasculitis 2025
BSR has published a new set of management recommendations for ANCA-associated vasculitis (AAV), serving as an update to our AAV guideline last published in 2017. Find out more via our blog. Join guideline working group Chair, Lorraine Harper, and group members Rosemary Hollick, Harold Wilson-Morkeh, Georgina Ducker and expert by experience member, Zoi Anastasa, in a roundtable discussion hosted by Prof Ernest Choy, Editor in Chief of Rheumatology to find out what is included in the publ...
Talking Rheumatology
BSR has published an updated life-course guideline for the prescription and monitoring of conventional synthetic disease modifying anti-rheumatic drugs (csDMARDs). Find out more via our blog. Join guideline working group Chair, Louise Mercer, and group members James Galloway, Katie Bechman, Akhila Kavirayani and Alan Davidson, in a roundtable discussion hosted by Prof Ernest Choy, Editor in Chief of Rheumatology to find out what is included in the publication and what has changed since ...
